Malaysia-based Hovid seeks US FDA nod for tocotrienols

PETALING JAYA: Investors may have overlooked Hovid Bhd’s pharmaceutical business and efforts to register tocotrienols (a type of Vitamin E) as a US Food and Drug Administration (FDA)-approved drug, said CIMB Investment Bank Bhd in a report.

It is currently sold as a dietary supplement under the brand name “Tocovid” but unlike drugs, dietary supplements cannot make the claim of being able to prevent, treat or cure illnesses due to regulatory restrictions.